清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria

医学 血压 药丸 随机对照试验 中止 随机化 耐受性 意向治疗分析 氨氯地平 不利影响 内科学 药理学
作者
Dike Ojji,Abdul Salam,Mahmoud U. Sani,Okechukwu S. Ogah,Aletta E. Schutte,Mark D. Huffman,Rashmi Pant,Arpita Ghosh,Rupasvi Dhurjati,Josyula K. Lakshmi,Nanna Ripiye,Ikechukwu A. Orji,Shehu A. Kana,Tijjani Abdussalam,Abdulgafar Lekan Olawumi,Isiaka M. Alfa,Olanike Allison Orimolade,Moses O. Ajayi,Anthony Rodgers
出处
期刊:JAMA [American Medical Association]
卷期号:332 (13): 1070-1070 被引量:35
标识
DOI:10.1001/jama.2024.18080
摘要

Importance: With the high burden of hypertension in sub-Saharan Africa, there is a need for effective, safe and scalable treatment strategies. Objective: To compare, among Black African adults, the effectiveness and safety of a novel low-dose triple-pill protocol compared with a standard-care protocol for blood pressure lowering. Design and Setting: Randomized, parallel-group, open-label, multicenter trial conducted in public hospital-based family medicine clinics in Nigeria. Participants: Black African adults with uncontrolled hypertension (≥140/90 mm Hg) who were untreated or receiving a single blood pressure-lowering drug. Interventions: Participants were randomly allocated to low-dose triple-pill or standard-care protocols. The triple-pill protocol involved a novel combination of telmisartan, amlodipine, and indapamide in triple one-quarter, one-half, and standard doses (ie, 10/1.25/0.625 mg, 20/2.5/1.25 mg, and 40/5/2.5 mg), with accelerated up-titration. The standard-care protocol was the Nigeria hypertension treatment protocol starting with amlodipine (5 mg). Main Outcomes and Measures: The primary effectiveness outcome was the reduction in home mean systolic blood pressure, and the primary safety outcome was discontinuation of trial treatment due to adverse events, both from randomization to month 6. Results: The first participant was randomized on July 19, 2022, and the last follow-up visit was on July 18, 2024. Among 300 randomized participants (54% female; mean age, 52 years; baseline mean home blood pressure, 151/97 mm Hg; and clinic blood pressure, 156/97 mm Hg), 273 (91%) completed the trial. At month 6, mean home systolic blood pressure was on average 31 mm Hg (95% CI, 28 to 33 mm Hg) lower in the triple-pill protocol group and 26 mm Hg (95% CI, 22 to 28 mm Hg) lower in the standard-care protocol group (adjusted difference, -5.8 mm Hg [95% CI, -8.0 to -3.6]; P < .001]). At month 6, clinic blood pressure control (<140/90 mm Hg) was 82% vs 72% (risk difference, 10% [95% CI, -2% to 20%]) and home blood pressure control (<130/80 mm Hg) was 62% vs 28% (risk difference, 33% [95% CI, 22% to 44%]) in the triple-pill compared with the standard-care protocol group; these were 2 of 21 prespecified secondary effectiveness end points. No participants discontinued trial treatment due to adverse events. Conclusions and Relevance: Among Black African adults with uncontrolled hypertension, a low-dose triple-pill protocol achieved better blood pressure lowering and control with good tolerability compared with the standard-care protocol. Trial Registration: Pan African Clinical Trials Registry Identifier: PACTR202107579572114.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
把饭拼好给你完成签到 ,获得积分10
2秒前
思源的应助被Agan采纳,获得10
4秒前
好运连连完成签到,获得积分10
45秒前
49秒前
52秒前
五月完成签到,获得积分10
52秒前
瘦瘦的枫叶完成签到 ,获得积分10
55秒前
sugar发布了新的文献求助10
57秒前
传奇3的应助被wuyy采纳,获得10
59秒前
酷波er的应助被sugar采纳,获得10
1分钟前
Omarkyarm完成签到,获得积分10
1分钟前
1分钟前
wuyy发布了新的文献求助10
1分钟前
圆月弯刀完成签到 ,获得积分10
1分钟前
合适乐巧完成签到 ,获得积分10
1分钟前
null的应助被mashibeo采纳,获得10
1分钟前
wuyy完成签到,获得积分20
1分钟前
赘婿的应助被wuyy采纳,获得10
1分钟前
2分钟前
wuyy发布了新的文献求助10
2分钟前
JUN完成签到,获得积分10
2分钟前
2分钟前
瞿人雄完成签到,获得积分10
2分钟前
没心没肺完成签到,获得积分10
2分钟前
keggin完成签到,获得积分10
2分钟前
2分钟前
alex的应助被科研通管家采纳,获得10
2分钟前
alex的应助被科研通管家采纳,获得10
2分钟前
2分钟前
CHENG驳回了李健的应助
2分钟前
11发布了新的文献求助10
2分钟前
田様的应助被shiqiyuan采纳,获得10
3分钟前
清风完成签到,获得积分10
3分钟前
3分钟前
LeonQiao发布了新的文献求助10
3分钟前
3分钟前
orixero的应助被小文同学采纳,获得10
3分钟前
4分钟前
CHENG发布了新的文献求助40
4分钟前
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8195184
求助须知:如何正确求助?哪些是违规求助? 9580915
关于积分的说明 21872990
捐赠科研通 7795171
什么是DOI,文献DOI怎么找? 3437967
关于科研通互助平台的介绍 2561276
邀请新用户注册赠送积分活动 2484678